The authors regret that the Graphical Abstract on p. vii, and Fig. 2, on p. 212 contain incorrect structures and apologise for any inconvenience caused. The correct structures are shown… Click to show full abstract
The authors regret that the Graphical Abstract on p. vii, and Fig. 2, on p. 212 contain incorrect structures and apologise for any inconvenience caused. The correct structures are shown below in the Graphical Abstract and in Fig. 2. Graphical abstract The heparanase has emerged as an attractive target for the development of anti-cancer therapy. This review highlights advances in the discovery of heparanase inhibitors.
               
Click one of the above tabs to view related content.